Psychiatry and Neurology, Neurology · San Francisco, CA
NPI
1174786123
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
950 Stockton St Ste 368
San Francisco, CA, 94108
Phone (415) 666-2536
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
2,319 services
Medicare patients, 2024
548
Average age 76
Drug cost, 2024
$1.6M
3,133 prescriptions
Company payments, 2025
$2,723
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joy S Meng was code 99215 (office e&m - established), 1,105 times for 426 patients. In total Joy S Meng billed 2,319 services in 25 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,105 | 426 | $165.44 | $183K |
| 99214 Office E&M - Established | Office | 181 | 90 | $113.79 | $21K |
| 99205 Office E&M - New | Office | 170 | 170 | $197.36 | $34K |
| 95800 Sleep Study | Office | 114 | 114 | $140.88 | $16K |
| 92548 Test - Miscellaneous | Office | 72 | 43 | $45.70 | $3,290 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 41 | 24 | $30.64 | $1,256 |
| 99497 Care Management/Coordination | Office | 29 | 26 | $81.79 | $2,372 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 26 | 26 | $26.00 | $676 |
| 99213 Office E&M - Established | Office | 24 | 23 | $90.60 | $2,174 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 18 | 13 | $53.65 | $966 |
| 99204 Office E&M - New | Office | 18 | 18 | $164.42 | $2,960 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 15 | 13 | $20.90 | $314 |
| 95811 Sleep Study | Office | 12 | 12 | $733.92 | $8,807 |
| 96132 Behavioral Health Services | Office | 11 | 11 | $125.58 | $1,381 |
By year: 2022 $378K for 11,615 services; 2023 $349K for 9,653 services; 2024 $288K for 2,319 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joy S Meng prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 368 prescriptions and refills. In total Joy S Meng wrote 3,133 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 368 | 1,024 | 118 | $17K |
| Gabapentin Generic | 334 | 937 | 139 | $6,466 |
| Propranolol Hcl Generic | 298 | 847 | 129 | $7,829 |
| Memantine Hcl Generic | 260 | 724 | 97 | $9,513 |
| Memantine Hcl Er Memantine Hcl | 185 | 486 | 67 | $34K |
| Zolpidem Tartrate Generic | 166 | 166 | 33 | $569 |
| Donepezil Hcl Generic | 105 | 309 | 35 | $1,740 |
| Levetiracetam Generic | 100 | 282 | 25 | $3,046 |
| Horizant Gabapentin Enacarbil | 81 | 171 | 18 | $140K |
| Neupro Rotigotine | 68 | 121 | 13 | $95K |
| Ongentys Opicapone | 60 | 144 | 16 | $87K |
| Rasagiline Mesylate Generic | 59 | 166 | 17 | $22K |
| Rytary Carbidopa/Levodopa | 57 | 96 | Under 11 | $88K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 56 | 147 | 17 | $1,592 |
| Topiramate Generic | 53 | 148 | 13 | $1,192 |
Brand drugs: 599 claims; generic drugs: 2,534 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joy S Meng $2,723 ($2,723 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $696.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $696 |
| Neurocrine BioSciences, Inc. NBIX | 11 | $363 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $250 |
| MDD US Operations, LLC | 10 | $241 |
| Lundbeck LLC | 7 | $192 |
| Amneal Pharmaceuticals LLC AMRX | 9 | $181 |
| SK Life Science, Inc. | 7 | $147 |
| Lilly USA, LLC LLY | 5 | $147 |
| Pfizer Inc. PFE | 9 | $139 |
| Merz Pharmaceuticals, LLC | 3 | $139 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.